Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9220775 Binding molecules specific for HER3 and uses thereof

Patent 9220775 was granted and assigned to MedImmune on December, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

December 29, 2015

0

Patent Application Number

143598640

Date Filed

November 20, 2012

0

Patent Citations Received

US Patent 11939394 Binding molecules that inhibit cancer growth

0

US Patent 11773170 Antibodies that bind EGFR and cMET

US Patent 11780925 ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene

Patent Primary Examiner

0

Patent abstract

The present invention relates to antibodies and antigen binding fragments thereof that bind the extracellular domain of the HER3 receptor and inhibit various HER3 receptor related functions via ligand-dependent and/or ligand-independent mechanisms. Also provided are compositions with increased half-life. In addition, the invention provides compositions and methods for diagnosing and treating diseases associated with HER3 mediated signal transduction.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9220775 Binding molecules specific for HER3 and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.